Fresenius SE & Co. KGaA is a healthcare group operating through two main segments: Fresenius Kabi and Fresenius Helios. Fresenius Kabi provides intravenous (I.V.) generics, biosimilars, and medical nutrition, including enteral nutrition products like NutriChef. It operates the mAbxience biosimilars platform and manufactures products in Europe and North America. Fresenius Helios is a private hospital operator with facilities in Germany and Spain, including the Quirónsalud network. The group also offers hospital services through Fresenius Health Services, which provides technical infrastructure and support to external clients. Fresenius was founded in 1912 and has historically been involved in dialysis through its former subsidiary Fresenius Medical Care, which it deconsolidated in 2021. The company serves patients with critical and chronic illnesses across Europe and North America.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Healthcare Plans Homepage fresenius.com
Sector Healthcare IR page fresenius.com/for-us-Investors
Tags
biosimilars, intravenous generics, medical nutrition, private hospitals, hospital services, enteral nutrition, healthcare infrastructure, Fresenius Kabi, Fresenius Helios, Quirónsalud, mAbxience, NutriChef, Fresenius Health Services, Idacio, Fresenius Medical Care
Press page —

Metrics

Valuation  
Market cap € 23.856B
P/E 13.75
P/BV 1.17
P/S 1.04
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 6.7%
ROI 6.8%
ROIC 6.8%
Profit margin 5.8%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 12.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Revenue 22.873B 21.833B 22.299B 40.84B 37.52B 36.277B 35.409B — — —
Net profit 1.334B 296M -45M 1.372B 2.819B 2.823B 3.029B — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Fresenius SE & Co. KGaA (ticker FRE), listed in Germany.